AZN
Astrazeneca PLC
63.25
USD
This page is just a preview of the data found in TrendSpider’s full version
Astrazeneca PLC stock is down -1.32% since 30 days ago. The next earnings date is Feb 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 48% of the previous 24 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 3 PUTs, 7 CALLs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 27 Nov 19:57 | 17 Jan, 2025 | 105.00 | 0 | ||
| 28 Nov 16:11 | 19 Jan, 2024 | 50.00 | 1150 | ||
| 29 Nov 16:01 | 19 Jan, 2024 | 30.00 | 474 | ||
| 29 Nov 17:47 | 19 Apr, 2024 | 72.50 | 735 | ||
| 29 Nov 17:48 | 19 Jan, 2024 | 32.50 | 2 | ||
| 29 Nov 20:00 | 19 Jan, 2024 | 27.50 | 0 | ||
| 29 Nov 20:22 | 19 Jan, 2024 | 27.50 | 0 | ||
| 30 Nov 14:48 | 19 Jan, 2024 | 27.50 | 32 | ||
| 05 Dec 15:01 | 17 Jan, 2025 | 60.00 | 443 | ||
| 06 Dec 15:16 | 17 Jan, 2025 | 65.00 | 412 |
AstraZeneca PLC focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex. The company serves primary care and specialty care physicians through distributors in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia.
